These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17245674)

  • 1. [Doping in adolescence].
    Kamber M; Mullis PE
    Ther Umsch; 2007 Feb; 64(2):83-9. PubMed ID: 17245674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance use in athletics: a sports psychiatry perspective.
    McDuff DR; Baron D
    Clin Sports Med; 2005 Oct; 24(4):885-97, ix-x. PubMed ID: 16169452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the prevalence of anabolic steroids, stimulants, and selected drugs subject to doping controls among elite sport students using analytical chemistry.
    Thevis M; Sauer M; Geyer H; Sigmund G; Mareck U; Schänzer W
    J Sports Sci; 2008 Aug; 26(10):1059-65. PubMed ID: 18608840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Doping].
    Kamber M; Villard G
    Praxis (Bern 1994); 1995 Sep; 84(36):970-7. PubMed ID: 7481289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doping, drugs and drug abuse among adolescents in the State of Thuringia (Germany): prevalence, knowledge and attitudes.
    Wanjek B; Rosendahl J; Strauss B; Gabriel HH
    Int J Sports Med; 2007 Apr; 28(4):346-53. PubMed ID: 17024651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system.
    Striegel H; Simon P; Frisch S; Roecker K; Dietz K; Dickhuth HH; Ulrich R
    Drug Alcohol Depend; 2006 Jan; 81(1):11-9. PubMed ID: 16009506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulant doping agents used in Brazil: prevalence, detectability, analytical implications, and challenges.
    Pereira HM; Sardela VF
    Subst Use Misuse; 2014 Jul; 49(9):1098-114. PubMed ID: 24766455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of substance use in ballet, dance sport, and synchronized swimming: results of a longitudinal study.
    Zenic N; Peric M; Zubcevic NG; Ostojic Z; Ostojic L
    Med Probl Perform Art; 2010 Jun; 25(2):75-81. PubMed ID: 20795336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of testosterone and anabolic androgenic steroids in sport].
    Medraś M; Jóźków P
    Endokrynol Pol; 2009; 60(3):204-9. PubMed ID: 19569021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
    Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B
    Sante; 2005; 15(3):167-70. PubMed ID: 16207578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance-enhancing drug use in young athletes.
    Laos C; Metzl JD
    Adolesc Med Clin; 2006 Oct; 17(3):719-31; abstract xii. PubMed ID: 17030288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse cardiovascular effects of doping in athletes.
    Tlili R; Zayed S; Saoudi W; Azaiez F; Hentati R; Ben Ameur Y
    Tunis Med; 2019 Nov; 97(11):1211-1218. PubMed ID: 32173820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recreational athletes and doping--a survey in 11 gyms in the area of Frankfurt/Main].
    Raschka C; Chmiel C; Preiss R; Boos C
    MMW Fortschr Med; 2013 Jul; 155 Suppl 2():41-3. PubMed ID: 24930320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are anabolic-androgenic steroid users polysubstance users?
    Dunn M
    J Sci Med Sport; 2009 Nov; 12(6):e1-2. PubMed ID: 19119065
    [No Abstract]   [Full Text] [Related]  

  • 15. Can we measure accurately the prevalence of doping?
    Lentillon-Kaestner V; Ohl F
    Scand J Med Sci Sports; 2011 Dec; 21(6):e132-42. PubMed ID: 22126721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk profile of male college athletes who use performance-enhancing substances.
    Buckman JF; Yusko DA; White HR; Pandina RJ
    J Stud Alcohol Drugs; 2009 Nov; 70(6):919-23. PubMed ID: 19895768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Doping in mass sport--what the family doctor needs to know].
    Fritz M
    MMW Fortschr Med; 2008 Nov; 150(46):39, 41. PubMed ID: 19130730
    [No Abstract]   [Full Text] [Related]  

  • 18. [The fight against doping: international and national efforts as exemplified by the Convention of the Council of Europe and the doping regulations of the Swiss National Association for Sports].
    Kamber M
    Schweiz Z Sportmed; 1990 Sep; 38(2):101-6. PubMed ID: 2218473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current Status of Doping in Japan Based on Japan Anti-Doping Disciplinary Panels of the Japan Anti-Doping Agency (JADA): A Suggestion on Anti-Doping Activities by Pharmacists in Japan].
    Imanishi T; Kawabata T; Takayama A
    Yakugaku Zasshi; 2017; 137(7):883-891. PubMed ID: 28674304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes.
    Deligiannis A; Björnstad H; Carre F; Heidbüchel H; Kouidi E; Panhuyzen-Goedkoop NM; Pigozzi F; Schänzer W; Vanhees L;
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):687-94. PubMed ID: 17001206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.